newsfilter
← Latest News
GlobeNewswire·

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

  • Foghorn Therapeutics Inc. (NASDAQ: FHTX) announced that management will attend the Guggenheim Second Annual Healthcare Innovation Conference, Stifel 2025 Healthcare Conference, & Jefferies 2025 London Healthcare Conference.
  • Adrian Gottschalk, President & Chief Executive Officer, will lead presentations at all three events.
  • The Guggenheim Fireside Chat is scheduled for Monday, November 10, 2025, at 11:00 a.m. ET.
  • The Stifel 2025 Healthcare Conference presentation is set for Thursday, November 13, 2025, at 4:00 p.m. ET.
  • The Jefferies London Healthcare Conference Fireside Chat will take place on Wednesday, November 19, 2025, at 10:30 a.m. GMT.
  • One-on-one meetings with management will be available at each conference.
  • Webcasts of the presentations will be accessible via the Investors section of www.foghorntx.com for 90 days.
  • Foghorn Therapeutics utilizes its Gene Traffic Control platform to develop medicines targeting chromatin regulatory systems, with an initial focus on oncology.